Article metrics

Download PDFPDF

402 Study design and rationale for the efficacy and safety assessment of daxdilimab, a selective plasmacytoid dendritic cell depleter, in a phase 2 trial of patients with moderate-to-severe primary discoid lupus erythematosus

 

Online download statistics by month:

Online download statistics by month: May 2024 to October 2024

AbstractFullPdf
May 20243707
Jun 202467012
Jul 20247008
Aug 20243606
Sep 20245404
Oct 20245307
Total317044